doi: 10.1177/2042018814543483 185 FarshchianMAnsarASobhanMHoseinpoorV
Because it engages an additional glucagon pathway beyond dual-agonist compounds, retatrutide is frequently studied alongside Semaglutide (a mono-agonist) and Tirzepatide (a dual-agonist) to compare multi-receptor pharmacology
The authors KK, KR declared that they were an editorial board member of Frontiers at the time of submission
Due to its popularity, counterfeit products are being sold online as research chemicals or not for human use
While rare, theres also a risk of developing more serious side effects, including pancreatitis, kidney damage, gallbladder disorders, or a bowel obstruction
What the Evidence Supports for Lean Mass Preservation The good news is that the muscle loss associated with GLP-1 therapy is modifiable